Mechanisms regulating invasiveness and growth of endometriosis lesions in rat experimental model and in humans

Fertility and Sterility

Volumn 93, Issue 8, 2010, Pages 2701-2705

  Sotnikova, Natalia Yu ^a   Antsiferova, Yulia S ^a   Posiseeva, Lyubov V ^a   Shishkov, Dmitrii N ^a   Posiseev, Denis V ^a   Filippova, Ekaterina S ^a  

^a Research Institute of Maternity and Childhood   (Russian Federation)

Author keywords

cytokines; Endometriosis; endometrium; invasiveness; MMP 2; rat model; TGF 2; TIMP 2

Indexed keywords

GELATINASE A; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRANSFORMING GROWTH FACTOR BETA2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; ENDOMETRIOSIS; FEMALE; GENE SEQUENCE; HUMAN; MONONUCLEAR CELL; NONHUMAN; PERITONEAL FLUID; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS;

ADULT; ANIMALS; ASCITIC FLUID; DISEASE MODELS, ANIMAL; ENDOMETRIOSIS; ENDOMETRIUM; FEMALE; HUMANS; MATRIX METALLOPROTEINASE 2; RATS; RNA, MESSENGER; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TRANSFORMING GROWTH FACTOR BETA2;

EID: 77952101625     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2009.11.024     Document Type: Article

References (19)

1. Rodgers P.A., D'Hooghe T.M., Fazleabas A., Gargett C.E., Giudice L.C., Montgomery G.W., et al. Priorities for endometriosis research: recommendation from an international consensus workshop. Reprod Sci 16 (2009) 335-346
2. Bondza P.K., Mahenx R., and Akoum A. Insights into endometriosis-associated endometrial dysfunctions: a review. Front Biosci (Elite Ed.) 1 (2009) 415-428
3. Nap A.W., Groothuis P.G., Demir A.Y., Evers J.L.H., and Dunselman G.A.J. Pathogenesis of endometriosis. Best Prac Res Clin Obstet Gynecol 18 (2004) 233-244
4. Colette T., Bellehumeur C., Kats R., Maheux R., Mailloux J., Villeneuve M., et al. Evidence for an increased release of proteolytic activity by the eutopic endometrial tissue in women with endometriosis and for involvement of matrix metalloproteinase-9. Hum Reprod 19 (2004) 1257-1264
5. Di Carlo C., Bonifacio M., Tommaselli G.A., Bifulco G., Guerra G., and Nappi C. Metalloproteinases, vascular endothelial growth factor, and angiopoietin 1 and 2 in eutopic and ectopic endometrium. Fertil Steril 91 (2009) 2315-2323
6. Laudanski P., Szamatowicz J., and Ramel P. Matrix metalloproteinase-13 and membrane typr-1 matrix metalloproteinase in peritoneal fluid of women with endometriosis. Gynecol Endocrinol 21 (2005) 106-110
7. Uciide I., Ihara T., and Sugamata M. Pathological evaluation of the rat endometriosis model. Fertil Steril 78 (2002) 782-786
8. Braundmeier A.G., Fazleabas A.T., Lessey B.A., Guo H., Toole B.P., and Nowak R.A. Extracellular matrix metalloproteinase inducer regulates metalloproteinases in human uterine endometrium. J Clin Endocrin Metab 91 (2006) 2358-2365
9. Sillem M., Prifti S., Koch A., Naher M., Jauckus J., and Runnebaum B. Regulation of matrix metalloproteinases and their inhibitors in uterine endometrial cells of patients with and without endometriosis. Eur J Obstet Gynecol Reprod Biol 95 (2001) 167-174
10. Mulayim N., Savlu A., Guzeloglu-Kayisli O., Kayisli U.A., and Arici A. Regulation of endometrial stromal cell matrix metalloproteinase activity and invasiveness by interleukin-8. Fertil Steril 81 (2004) 904-911
11. Dmowski W.P., and Braun D.P. Immunology of endometriosis. Best Prac Res Clin Obstet Gynecol 18 (2004) 245-263
12. Vernon M.W., and Wilson E.A. Studies on the surgical induction of endometriosis in the rat. Fertil Steril 44 (1985) 684-694
13. Velden van V.H.J., Hochhaus A., Cazzaniga G., Szczepanski T., Gabert J., and Dongen van J.J.M. Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: priciples, approaches, and laboratoty aspects. Leukemiea 17 (2003) 1013-1034
14. Karahan N., Güney M., Baspinar S., Oral B., Kapucuoglu N., and Mungan T. Expression of gelatinase (MMP-2 and MMP-9) and cyclooxygenase-2 (COX-2) in endometrial carcinoma. Uer J Gynaecol Oncol 28 (2007) 184-188
15. Cox K.E., Piva M., and Sharpe-Timms K.L. Differential regulation of matrix metalloproteinase-3 gene expression in endometriotic lesions compared with endometrium. Biol Reprod 65 (2001) 1297-1303
16. Huang H.F., Hong L.H., Tan Y., and Sheng J.Z. Matrix metalloproteinase 2 is associated with changes in steroid hormones in the sera and peritoneal fluid of patients with endometriosis. Fertil Steril 81 (2004) 1235-1239
17. Bierie B., and Moses H.L. TGFβ and cancer. Cytokines Growth Factors Rev 17 (2006) 29-40
18. Jones R.L., Stoikos C., Findlay J.K., and Salamonsen L.A. TGF-β superfamily expression and actions in the endometrium and placenta. Reproduction 132 (2006) 217-232
19. Loverro G., Maiorano E., Napoli A., Selvaggi L., Marra E., and Perlino E. Transforming growth factor-beta 1 and insulin-like growth factor-1 expression in ovarian endometriotic cysts: a preliminary study. Int J Mol Med 4 (2001) 423-429